Nuvation Bio Inc.
NUVB
$4.40
-$0.11-2.33%
NYSE
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 219.09% | 171.47% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 219.09% | 171.47% | |||
| Cost of Revenue | -61.81% | 30.01% | |||
| Gross Profit | 315.37% | 332.92% | |||
| SG&A Expenses | 7.94% | -2.92% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.13% | 1.65% | |||
| Operating Income | 39.69% | 11.25% | |||
| Income Before Tax | 34.41% | 5.45% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 34.41% | 5.45% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 34.41% | 5.45% | |||
| EBIT | 39.69% | 11.25% | |||
| EBITDA | 40.08% | 11.60% | |||
| EPS Basic | 34.75% | 5.95% | |||
| Normalized Basic EPS | 34.77% | 5.91% | |||
| EPS Diluted | 34.75% | 5.95% | |||
| Normalized Diluted EPS | 34.77% | 5.91% | |||
| Average Basic Shares Outstanding | 0.57% | 0.48% | |||
| Average Diluted Shares Outstanding | 0.57% | 0.48% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||